HKSE · 8372.HK
Grand Brilliance Group Holdings Limited
HK$0.17+HK$0.00 (+0.61%)
Grand Brilliance Group Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 7.78% below the high.
Loading market information…
HKSE · 0401.HK · HKD
Stock price, earnings
Quote as of Oct 30, 2026, 06:05 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Wanjia Group Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 47.85% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Wanjia Group Holdings Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Wanjia Group Holdings Limited operates as an investment holding company, primarily engaged in the wholesale and distribution of pharmaceutical products across mainland China and Hong Kong. The firm also offers hemodialysis treatment and associated consultancy services. Its pharmaceutical goods are supplied to a diverse client base within Fujian province, including hospitals, various healthcare institutions, pharmaceutical retail chains, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics. Established in 2004, the company is headquartered in Kowloon, Hong Kong.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:51 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$0.17+HK$0.00 (+0.61%)
Grand Brilliance Group Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 7.78% below the high.
HK$0.21+HK$0.01 (+5.5%)
Republic Healthcare Limited’s quoted price sits in the upper half of its reported 52-week range, 24.64% below the high.
HK$0.11-HK$0.01 (-5.88%)
Raily Aesthetic Medicine International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 42.86% below the high.
HK$0.15-HK$0.00 (-0.65%)
Medicskin Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 24.0% below the high.
HK$0.07-HK$0.00 (-1.35%)
China Healthwise Holdings Ltd.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
HK$0.32HK$0.00 (0.0%)
Qianhai Health Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 77.5% below the high.
HK$0.06-HK$0.00 (-1.61%)
Elegance Optical International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 64.12% below the high.
HK$0.45+HK$0.01 (+2.27%)
Universal Health International Group Holding Limited’s quoted price sits in the lower half of its reported 52-week range, 91.6% below the high.
